commited to your health blueline.png

Drug Recalls

From time to time, certain items that Kinney Drugs carries may be recalled by the manufacturer. When this happens, we will display details on the recalled item, along with instructions, to keep you informed on what to do and how to return the recalled item.

November 19th, 2019: Amneal is voluntarily recalling Ranitidine due to potential NDMA levels above those established by the FDA.
 

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
 

If you have received a prescription for Amneal Ranitidine, please stop taking the medication and return it to your local Kinney Drugs for safe and proper disposal. Your Kinney Pharmacist will then reach out to your prescriber to obtain a prescription for an alternative medication as needed. You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

October 31, 2019: Pharmaceutical manufacturer Lannett has initiated a voluntary nationwide recall on Ranitidine syrup (Ranitidine Oral Solution, USP), 15mg/mL due to levels of N-Nitrosodimethylamine (NDMA) above the limit recently established by the FDA for Ranitidine Hydrochloride Syrup (Ranitidine Oral Solution, USP). The recall follows the USFDA's caution note alerting patients and health care professionals that NDMA was found in certain samples of Ranitidine.

 

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

 

If you have received a prescription for Ranitidine syrup, please stop taking the medication and return it to your local Kinney Drugs for safe and proper disposal. Your Kinney Pharmacist will then reach out to your prescriber to obtain a prescription for an alternative medication as needed. You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

October 28, 2019: Pharmaceutical manufacturer Dr. Reddy's Laboratories, Ltd. has initiated a voluntary nationwide recall for prescription products of Ranitidine capsules in the 150mg and 300mg strengths sold in the U.S. due to confirmed contamination with Nitrosodimethylamine (NDMA) above levels established by the FDA. The recall follows the USFDA's caution note alerting patients and health care professionals that NDMA was found in certain samples of Ranitidine. To date, Dr. Reddy's has not received any reports of adverse events related to the recall of Dr. Reddy's Ranitidine products.

 

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

 

If you have received a prescription for Dr. Reddy's brand Ranitidine capsules only in either the 150mg or 300mg strength, please stop taking the medication and return it to your local Kinney Drugs for safe and proper disposal. Your Kinney Pharmacist will then reach out to your prescriber to obtain a prescription for an alternative medication as needed. You should contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.

 

View Product Recall List

 

For further information on product recalls, please visit recalls.gov.